Search

Author/Creator Sulkowski, Mark

1. Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial. Issue 9973 (21st March 2015)

Authors:
Sulkowski, Mark; Hezode, Christophe; Gerstoft, Jan; Vierling, John M; Mallolas, Josep; Pol, Stanislas; Kugelmas, Marcelo; Murillo, Abel; Weis, Nina; Nahass, Ronald; Shibolet, Oren; Serfaty, Lawrence; Bourliere, Marc; DeJesus, Edwin; Zuckerman, Eli; Dutko, Frank; Shaughnessy, Melissa; Hwang, Peggy...
Journal:
Lancet
Issue:
Volume 385:Issue 9973(2015)
Page Start:
1087
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial. Issue 9973 (21st March 2015)

Authors:
Sulkowski, Mark; Hezode, Christophe; Gerstoft, Jan; Vierling, John M; Mallolas, Josep; Pol, Stanislas; Kugelmas, Marcelo; Murillo, Abel; Weis, Nina; Nahass, Ronald; Shibolet, Oren; Serfaty, Lawrence; Bourliere, Marc; DeJesus, Edwin; Zuckerman, Eli; Dutko, Frank; Shaughnessy, Melissa; Hwang, Peggy...
Journal:
Lancet
Issue:
Volume 385:Issue 9973(2015)
Page Start:
1087
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV–Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial. (7th March 2018)

Authors:
Kleinstein, Sarah E; Shea, Patrick R; Stamm, Luisa M; Sulkowski, Mark; Goldstein, David B; Naggie, Susanna
Journal:
Clinical infectious diseases
Issue:
Volume 66:Number 12(2018)
Page Start:
1953
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s. Issue 1 (12th December 2019)

Authors:
Venuto, Charles S.; Cramer, Yoninah S.; Rosenkranz, Susan L.; Sulkowski, Mark; Wyles, David L.; Cohen, Daniel E.; Schmidt, Jeffrey; Alston‐Smith, Beverly L.; Morse, Gene D.
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 1(2020)
Page Start:
132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non‐adherence. Issue 12 (30th April 2020)

Authors:
Sulkowski, Mark; Luetkemeyer, Annie F.; Wyles, David L.; Martorell, Claudia; Muir, Andrew; Weisberg, Ilan; Gordon, Stuart C.; McLain, Richard; Huhn, Gregory
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 51:Issue 12(2020)
Page Start:
1384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Patient's Perspectives of Experimental HCV-Positive to HCV-Negative Renal Transplantation: Report from a Single Site. Issue 1 (2nd January 2020)

Authors:
Van Pilsum Rasmussen, Sarah E.; Seaman, Shanti; Brown, Diane; Desai, Niraj; Sulkowski, Mark; Segev, Dorry L.; Durand, Christine M.; Sugarman, Jeremy
Journal:
AJOB empirical bioethics
Issue:
Volume 11:Issue 1(2020)
Page Start:
40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Network‐based recruitment of people who inject drugs for hepatitis C testing and linkage to care. Issue 7 (2nd March 2020)

Authors:
Falade‐Nwulia, Oluwaseun; Ward, Kathleen M.; McCormick, Sean; Mehta, Shruti H.; Pitts, Stephanie R.; Katz, Stephanie; Chander, Geetanjali; Thomas, David L.; Sulkowski, Mark; Latkin, Carl A.
Journal:
Journal of viral hepatitis
Issue:
Volume 27:Issue 7(2020)
Page Start:
663
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study. Issue 6 (30th July 2014)

Authors:
Hézode, Christophe; Hirschfield, Gideon M; Ghesquiere, Wayne; Sievert, William; Rodriguez-Torres, Maribel; Shafran, Stephen D; Thuluvath, Paul J; Tatum, Harvey A; Waked, Imam; Esmat, Gamal; Lawitz, Eric J; Rustgi, Vinod K; Pol, Stanislas; Weis, Nina; Pockros, Paul J; Bourlière, Marc; Serfaty, Law...
Journal:
Gut
Issue:
Volume 64:Issue 6(2015)
Page Start:
948
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co‐infected Adults. Issue 2 (19th August 2019)

Authors:
Sterling, Richard K.; King, Wendy C.; Wahed, Abdus S.; Kleiner, David E.; Khalili, Mandana; Sulkowski, Mark; Chung, Raymond T.; Jain, Mamta K.; Lisker‐Melman, Mauricio; Wong, David K.; Ghany, Marc G.
Journal:
Hepatology
Issue:
Volume 71:Issue 2(2020)
Page Start:
411
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗